CLINICAL_TRIALS
trial_result
· 2016-12-07
Clinical Trial Update: Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation) [Phase 2]
Summary
The Phase 2 study of GLPG1837 in cystic fibrosis patients with the G551D mutation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galapagos NV | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED